Defendant Name: Elanco Animal Health Inc.

Defendant Type: Public Company
SIC Code: 2834
CUSIP: 28414H10

Initial Case Details

Legal Case Name In the Matter of Elanco Animal Health Inc.
First Document Date 12-Nov-2024
Initial Filing Format Administrative Action
File Number 3-22309
Allegation Type Issuer Reporting and Disclosure

Violations Alleged

Exchange Act
• Rule 12b-20
• Sec 13(a)
• Rule 13a-1
• Rule 13a-11
• Rule 13a-13
• Rule 13a-15
Securities Act
• Sec 17(a)(2)
• Sec 17(a)(3)

Resolutions

First Resolution Date 12-Nov-2024
Headline Total Penalty and Disgorgement $15,000,000

Related Documents:

33-11326 12-Nov-2024 Administrative Proceeding
Order Instituting Cease-and-Desist Proceedings Pursuant to Section 8A of the Securities Act of 1933 and Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing a Cease-and-Desist Order
On November 12, 2024, the SEC instituted settled cease-and-desist proceedings against Elanco Animal Health Inc., stating: "This matter concerns Elanco’s failure to disclose material information concerning its sales practices that rendered statements it made about its revenue growth misleading."
33-11326-s 12-Nov-2024 Administrative Summary
SEC Charges Indiana-Based Animal Health Products Company with Antifraud Violations
On November 12, 2024, the SEC "announced antifraud charges against Elanco Animal Health Inc. for misleading investors when it made statements about its revenue growth and end-user demand without also disclosing its reliance on certain quarter-end sales incentives that were necessary to achieve that revenue and caused its distributors to purchase goods in excess of existing end user demand. Elanco has agreed to pay $15 million to settle the charges."